3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Neoplasms
2
Melanoma
2
Hematologic Neoplasms
2
Febrile Neutropenia
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neutropenia
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Liver Neoplasms
1
Hematologic Diseases
1
Early Stage Non-Small Cell Lung Cancer
1
Clostridium Infections
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
9
glofitamab
4
Whole-Body Irradiation
4
Rituximab
4
fludarabine phosphate
3
fludarabine
3
Mycophenolic Acid
3
Melphalan
3
Doxorubicin
3
polatuzumab vedotin
2
pirtobrutinib
2
pembrolizumab
2
obinutuzumab
2
Tacrolimus
2
Sirolimus
2
Prednisone
2
Busulfan
2
zanubrutinib
1
venetoclax
1
relmacabtagene autoleucel
1
pegfilgrastim
1
axicabtagene ciloleucel
1
Vincristine
1
Triamcinolone
1
Specimen Handling
1
Receptors, Chimeric Antigen
1
Prednisolone
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Vancomycin
×
1 year
×
Clear all
No trials found.